Cogent Biosciences Statistics
Total Valuation
COGT has a market cap or net worth of $6.92 billion. The enterprise value is $6.30 billion.
| Market Cap | 6.92B |
| Enterprise Value | 6.30B |
Important Dates
The next estimated earnings date is Tuesday, August 4, 2026, before market open.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
COGT has 170.91 million shares outstanding. The number of shares has increased by 6.75% in one year.
| Current Share Class | 170.87M |
| Shares Outstanding | 170.91M |
| Shares Change (YoY) | +6.75% |
| Shares Change (QoQ) | +8.12% |
| Owned by Insiders (%) | 0.56% |
| Owned by Institutions (%) | 113.56% |
| Float | 160.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 149.50 |
| PB Ratio | 12.75 |
| P/TBV Ratio | 12.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.14, with a Debt / Equity ratio of 0.39.
| Current Ratio | 15.14 |
| Quick Ratio | 14.94 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -84.69 |
Financial Efficiency
Return on equity (ROE) is -85.72% and return on invested capital (ROIC) is -41.81%.
| Return on Equity (ROE) | -85.72% |
| Return on Assets (ROA) | -38.13% |
| Return on Invested Capital (ROIC) | -41.81% |
| Return on Capital Employed (ROCE) | -42.84% |
| Weighted Average Cost of Capital (WACC) | 5.97% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.37M |
| Employee Count | 258 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +314.21% in the last 52 weeks. The beta is 0.34, so COGT's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | +314.21% |
| 50-Day Moving Average | 35.04 |
| 200-Day Moving Average | 32.76 |
| Relative Strength Index (RSI) | 76.78 |
| Average Volume (20 Days) | 3,392,253 |
Short Selling Information
The latest short interest is 13.45 million, so 7.87% of the outstanding shares have been sold short.
| Short Interest | 13.45M |
| Short Previous Month | 11.52M |
| Short % of Shares Out | 7.87% |
| Short % of Float | 8.36% |
| Short Ratio (days to cover) | 5.69 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -362.04M |
| Pretax Income | -354.30M |
| Net Income | -354.30M |
| EBITDA | -359.49M |
| EBIT | -362.04M |
| Earnings Per Share (EPS) | -$2.51 |
Balance Sheet
The company has $866.38 million in cash and $238.65 million in debt, with a net cash position of $627.73 million or $3.67 per share.
| Cash & Cash Equivalents | 866.38M |
| Total Debt | 238.65M |
| Net Cash | 627.73M |
| Net Cash Per Share | $3.67 |
| Equity (Book Value) | 607.69M |
| Book Value Per Share | 3.18 |
| Working Capital | 819.82M |
Cash Flow
In the last 12 months, operating cash flow was -$284.82 million and capital expenditures -$1.46 million, giving a free cash flow of -$286.27 million.
| Operating Cash Flow | -284.82M |
| Capital Expenditures | -1.46M |
| Depreciation & Amortization | 2.55M |
| Net Borrowing | 217.76M |
| Free Cash Flow | -286.27M |
| FCF Per Share | -$1.67 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
COGT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.75% |
| Shareholder Yield | -6.75% |
| Earnings Yield | -5.12% |
| FCF Yield | -4.13% |
Analyst Forecast
The average price target for COGT is $54.25, which is 33.92% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $54.25 |
| Price Target Difference | 33.92% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 9, 2020. It was a reverse split with a ratio of 1:4.
| Last Split Date | Nov 9, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |